![Phillip Chan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Chan
Directeur Général chez
CYTOSORBENTS CORPORATION
Fortune : 856 516 $ au 31/05/2026
Profil
Phillip P.
Chan was the founder of Andrew Technologies LLC, founded in 2006, where the title held was Director from 2010 to 2011.
Dr. Chan is the founder of CytoSorbents Europe GmbH, founded in 2012, holding the title of Co-Managing Director since 2012.
Dr. Chan currently works at CytoSorbents Corp.
as Chief Executive Officer & Director since 2020, with employment starting in 2008.
Formerly, Dr. Chan was a Partner at Tech Council Ventures LLC.
Education includes undergraduate studies at Cornell University and a doctorate from Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 1 744 432 ( 2,78% ) | 856 516 $ | 31/05/2026 |
Postes actifs de Phillip Chan
| Sociétés | Poste | Début |
|---|---|---|
| CYTOSORBENTS CORPORATION | Directeur Général | 24/07/2008 |
CytoSorbents Europe GmbH
 CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Directeur Général | 01/02/2012 |
Anciens postes connus de Phillip Chan
| Sociétés | Poste | Fin |
|---|---|---|
Tech Council Ventures LLC
 Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses on the board range of sector and industries . It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. It takes board seat and acts as lead investor. | Private Equity Investor | 30/06/2009 |
Andrew Technologies LLC
 Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Fondateur | - |
Formation de Phillip Chan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Tech Council Ventures LLC
Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses on the board range of sector and industries . It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. It takes board seat and acts as lead investor. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
Andrew Technologies LLC
Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Health Technology |
CytoSorbents Europe GmbH
CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Distribution Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
